NASDAQ:SAGE

Delisted

Sage Therapeutics Stock News

Healthcare > Biotechnology

Buy SAGE

*Your capital is at risk

$8.68

+0 (+0%)

At Close: Oct 30, 2025

Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Securities Violations And Investors With Losses Are Urged To Start Dialogues

06:15pm, Friday, 19'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

SAGE Rides on Zurzuvae Sales, Pipeline Setbacks a Concern

11:20am, Friday, 19'th Jul 2024

Sage Therapeutics' (SAGE) Zurzuvae, approved for treating postpartum depression, holds an excellent commercial opportunity. The recent pipeline setbacks are, however, an overhang.

The Schall Law Firm Is Investigating Sage Therapeutics Inc For Potential Securities Breaches And Encourages Investors Who Have Experienced Losses To Initiate Dialogues

05:15pm, Thursday, 18'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Is Under Examination For Possible Securities Violations By The Schall Law Firm, Investors Who Have Suffered Losses Are Urged To Begin Conversations

03:30pm, Wednesday, 17'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Encourages Investors With Losses To Initiate Dialogue, Sage Therapeutics Inc Is Under Scrutiny For Potential Securities Violations

03:45pm, Tuesday, 16'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Under Investigation By The Schall Law Firm For Possible Securities Breaches Urging Investors With Losses To Start Conversation

03:15pm, Monday, 15'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Begins Investigation Into Sage Therapeutics Inc For Potential Securities Violations And Urges Investors With Losses To Initiate Conversation

07:00pm, Saturday, 13'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Inquiry Into Sage Therapeutics Inc For Possible Securities Breaches Initiated By The Schall Law Firm Encouraging Investors With Losses To Start Dialogue

06:45pm, Friday, 12'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Under Investigation By The Schall Law Firm For Possible Securities Breaches Urging Investors With Losses To Start Conversation

02:30pm, Thursday, 11'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Initiates Inquiry Into Sage Therapeutics Inc For Potential Securities Violations And Encourages Investors With Losses To Establish Dialogue

02:00pm, Wednesday, 10'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Starts Investigation Into Sage Therapeutics Inc For Possible Securities Breaches And Urges Investors With Losses To Set Up Communication

02:45pm, Tuesday, 09'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Initiates Probe Into Sage Therapeutics Inc For Potential Securities Violations And Encourages Investors With Losses To Establish Communication

01:45pm, Monday, 08'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Begins Investigation Into Sage Therapeutics Inc For Suspected Securities Breaches And Promotes Investors With Losses To Get In Touch

11:00am, Sunday, 07'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Is Conducting An Inquiry Into Sage Therapeutics Inc For Likely Securities Infringements And Invites Impacted Investors To Reach Out

11:00am, Saturday, 06'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Initiates Examination Into Sage Therapeutics Inc For Possible Securities Violations And Encourages Affected Investors To Establish Contact

04:00pm, Friday, 05'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by